Table 2 Demographic characteristics of the eight patients with surgical site infections.

From: Morel–Lavallee lesions and number of surgeries for associated injuries predict surgical site infection risk following pelvic ring injury osteosynthesis

Case

Sex

Age, years

ISS

NISS

Faringer zone/Jones–Powell classification (open fracture)

Morel–Lavallee lesion

Number of other surgeries*

Colostomy

AE

Number of debridement surgeries

Duration of antibiotic therapy, weeks

Time to union, months

Pathogens

1

Male

55

32

41

I/3

Yes

14

Yes

Yes

3

8

8

E. coli, Bacteroides species

2

Female

49

18

22

I/3

No

10

Yes

No

5

8

5

Proteus, MRSA, B. fragilis

3

Female

55

17

17

I/3

No

4

No

No

1

3

8

MRSA

4

Female

45

16

26

–

Yes

8

Yes

Yes

6

8

5

E. coli

5

Female

67

36

41

–

Yes

4

No

Yes

5

8

7

MRSA

6

Female

16

19

27

–

No

4

No

No

1

2

4

MSSA

7

Female

68

17

17

–

Yes

2

No

Yes

1

4

5

E. coli

8

Male

53

17

17

–

No

4

No

Yes

1

4

10

Klebsiella pneumoniae

  1. B. fragilis Bacteroides fragilis, E. coli Escherichia coli, ISS injury severity score, NISS new injury severity score, AE arterial embolization, MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-sensitive Staphylococcus aureus, SSI surgical site infection.
  2. *The definition of “other surgeries” is surgeries for commitment injuries other than either osteosynthesis for pelvic ring injury or debridement surgery for surgical site infection of the pelvic ring.
Back to article page